SLNO
Soleno Therapeutics Inc.
Company Overview
| Mkt Cap | $3.15B | Price | $67.16 |
| Volume | 1.14M | Change | -3.06% |
| P/E Ratio | -17.9 | Open | $69.53 |
| Revenue | -- | Prev Close | $69.28 |
| Net Income | $-175.8M | 52W Range | $41.50 - $90.32 |
| Div Yield | N/A | Target | $119.82 |
| Overall | 48 | Value | 40 |
| Quality | 47 | Technical | 58 |
No chart data available
Stock Overview
Updated DailySoleno Therapeutics Inc. (SLNO) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $67.16 with a market capitalization of $3.15 billion. The stock is trading in the middle of its 52-week range, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows SLNO with a volume of 1.14 million shares. The stock opened up 0.36% from yesterday's close of $69.28. Current analyst estimates project earnings of $-0.91 per share for this year, with next year targeting $2.69.
SLNO demonstrates neutral technical outlook based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for SLNO include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 78.4%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:28 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SLNO | $67.16 | -3.1% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Soleno Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW